Neuropathies aiguës sévères induites par l’infection à SARS-CoV-2 [Acute severe neuropathies in the context of SARS-CoV-2 infection]
Details
Download: RMS_Neuropathies aigues sévères induites.pdf (136.62 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_FDBFA32A2C10
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Neuropathies aiguës sévères induites par l’infection à SARS-CoV-2 [Acute severe neuropathies in the context of SARS-CoV-2 infection]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
28/04/2021
Peer-reviewed
Oui
Volume
17
Number
736
Pages
828-830
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Various neuromuscular complications have been described in SARS-CoV-2 infection, especially Guillain-Barré syndrome (GBS) and Critical Illness neuromyopathy (CI-NM). Two representative cases are discussed below. It appears that GBS shares most of the characteristics of classical post-infectious GBS, but SARS-CoV-2 may contribute to the increased incidence of CI-NM. Other rare complications have been described, including Tapia Syndrome and Kawasaki-like multiple system inflammatory syndrome. The question of vaccination and the risk of immune-mediated neuropathies remains open, but the lack of reported cases is reassuring as these complications usually occur within 6 weeks after vaccination.
Keywords
Brain Diseases, COVID-19, Guillain-Barre Syndrome/epidemiology, Guillain-Barre Syndrome/etiology, Humans, SARS-CoV-2
Pubmed
Create date
19/05/2021 14:11
Last modification date
16/01/2024 8:14